BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 32609387)

  • 1. Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007783. PubMed ID: 32609387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Ramaratnam S; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD001909. PubMed ID: 32196639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD005612. PubMed ID: 35349176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine add-on therapy for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Marson AG
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD001909. PubMed ID: 38078494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin add-on for drug-resistant focal epilepsy.
    Panebianco M; Bresnahan R; Hemming K; Marson AG
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD005612. PubMed ID: 31287157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD011501. PubMed ID: 35285519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
    Nevitt SJ; Sudell M; Cividini S; Marson AG; Tudur Smith C
    Cochrane Database Syst Rev; 2022 Apr; 4(4):CD011412. PubMed ID: 35363878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures.
    Tjia-Leong E; Leong K; Marson AG
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007783. PubMed ID: 21154386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brivaracetam add-on therapy for drug-resistant epilepsy.
    Bresnahan R; Panebianco M; Marson AG
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD011501. PubMed ID: 30920649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003032. PubMed ID: 30734919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.
    Brigo F; Igwe SC; Lattanzi S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD003032. PubMed ID: 33475151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin add-on treatment for drug-resistant focal epilepsy.
    Panebianco M; Al-Bachari S; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD001415. PubMed ID: 33434292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine add-on for drug-resistant focal epilepsy.
    Bresnahan R; Atim-Oluk M; Marson AG
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012433. PubMed ID: 32129501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vigabatrin add-on therapy for drug-resistant focal epilepsy.
    Bresnahan R; Gianatsi M; Maguire MJ; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD007302. PubMed ID: 32730657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacosamide add-on therapy for focal epilepsy.
    Babar RK; Bresnahan R; Gillespie CS; Michael BD
    Cochrane Database Syst Rev; 2021 May; 5(5):CD008841. PubMed ID: 33998660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carisbamate add-on therapy for drug-resistant focal epilepsy.
    Lu C; Zheng J; Cao Y; Bresnahan R; Martin-McGill KJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012121. PubMed ID: 34870321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nevitt SJ; Sudell M; Tudur Smith C; Marson AG
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012065. PubMed ID: 31233229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rufinamide add-on therapy for drug-resistant epilepsy.
    Panebianco M; Prabhakar H; Marson AG
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011772. PubMed ID: 33179247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.
    Nolan SJ; Tudur Smith C; Weston J; Marson AG
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD001031. PubMed ID: 27841445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant and non-stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy.
    Eaton C; Yong K; Walter V; Mbizvo GK; Rhodes S; Chin RF
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013136. PubMed ID: 35844168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.